<産業資料/調査レポートの題名> 2022年7月15日

降圧薬の世界市場:治療クラス別(利尿薬、ACE阻害薬、カルシウムチャネル遮断薬、血管拡張薬、ベータアドレナリン遮断薬、その他)、流通経路別(小売薬局、病院薬局、Eコマース、その他)


◆英文タイトル:Antihypertensive Drugs Market by Therapeutic Class (Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, and Others) and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others Distribution Channel): Global Opportunity Analysis and Industry Forecast, 2019–2026

Chapter 1: Introduction

1.1. Report Description
1.2. Key Market Segments

1.2.1. List of Key Players Profiled In The Report

1.3. Research Methodology

1.3.1. Primary Research
1.3.2. Secondary Research
1.3.3. Analyst Tools And Models

Chapter 2: Executive Summary

2.1. Key Findings of The Study
2.2. Cxo Perspective

Chapter 3: Market Overview

3.1. Market Definition And Scope
3.2. Top Player Positioning

3.2.1. Top Investment Pockets

3.3. Key Forces Shaping Antihypertensive Industry/Market
3.4. Market Dynamics

3.4.1. Drivers

3.4.1.1. Surge In Geriatric Population Worldwide
3.4.1.2. Surge In Healthcare Expenditure Worldwide
3.4.1.3. Rise In Prevalence of Hypertension Across The Globe

3.4.2. Restraint

3.4.2.1. Patent Expirations of Blockbuster Drugs

3.4.3. Opportunity

3.4.3.1. High Growth Potential In Developing Economies

3.4.4. Impact Analyses

Chapter 4: Antihypertensive Drugs Market, By Drug Class

4.1. Overview

4.1.1. Market Size And Forecast

4.2. Diuretics

4.2.1. Key Market Trends, Growth Factors, And Opportunities
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Analysis By Country

4.3. Ace Inhibitors

4.3.1. Key Market Trends, Growth Factors, And Opportunities
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Analysis By Country

4.4. Calcium Channel Blockers

4.4.1. Key Market Trends, Growth Factors, And Opportunities
4.4.2. Market Size And Forecast, By Region
4.4.3. Market Analysis By Country

4.5. Beta-Adrenergic Blockers

4.5.1. Key Market Trends, Growth Factors, And Opportunities
4.5.2. Market Size And Forecast, By Region
4.5.3. Market Analysis By Country

4.6. Vasodilators

4.6.1. Key Market Trends, Growth Factors, And Opportunities
4.6.2. Market Size And Forecast, By Region
4.6.3. Market Analysis By Country

4.7. Others

4.7.1. Key Market Trends, Growth Factors, And Opportunities
4.7.2. Market Size And Forecast, By Region
4.7.3. Market Analysis By Country

Chapter 5: Antihypertensive Drugs Market, By End User

5.1. Overview

5.1.1. Market Size And Forecast

5.2. Retail Pharmacy

5.2.1. Market Size And Forecast, By Region
5.2.2. Market Analysis By Country

5.3. Hospital Pharmacy

5.3.1. Market Size And Forecast, By Region
5.3.2. Market Analysis By Country

5.4. E-Commerce Websites & Online Drug Stores

5.4.1. Market Size And Forecast, By Region
5.4.2. Market Analysis By Country

Chapter 6: Antihypertensive Drugs Market, By Region

6.1. Overview

6.1.1. Market Size And Forecast

6.2. North America

6.2.1. Key Market Trends And Opportunities
6.2.2. Market Analysis, By Country

6.2.2.1. U.S.

6.2.2.1.1. U.S. Market Size And Forecast, By Drug Class
6.2.2.1.2. U.S. Market Size And Forecast, By Distribution Channel

6.2.2.2. Canada

6.2.2.2.1. Canada Market Size And Forecast, By Drug Class
6.2.2.2.2. Canada Market Size And Forecast, By Distribution Channel

6.2.2.3. Mexico

6.2.2.3.1. Mexico Market Size And Forecast, By Drug Class
6.2.2.3.2. Mexico Market Size And Forecast, By Distribution Channel

6.2.3. North America Market Size And Forecast, By Drug Class
6.2.4. North America Market Size And Forecast, By Distribution Channel

6.3. Europe

6.3.1. Key Market Trends And Opportunities
6.3.2. Market Analysis, By Country

6.3.2.1. Germany

6.3.2.1.1. Germany Market Size And Forecast, By Drug Class
6.3.2.1.2. Germany Market Size And Forecast, By Distribution Channel

6.3.2.2. France

6.3.2.2.1. France Market Size And Forecast, By Drug Class
6.3.2.2.2. France Market Size And Forecast, By Distribution Channel

6.3.2.3. Uk

6.3.2.3.1. Uk Market Size And Forecast, By Drug Class
6.3.2.3.2. Uk Market Size And Forecast, By Distribution Channel

6.3.2.4. Italy

6.3.2.4.1. Italy Market Size And Forecast, By Drug Class
6.3.2.4.2. Italy Market Size And Forecast, By Distribution Channel

6.3.2.5. Rest of Europe

6.3.2.5.1. Rest of Europe Market Size And Forecast, By Drug Class
6.3.2.5.2. Rest of Europe Market Size And Forecast, By Distribution Channel

6.3.3. Europe Market Size And Forecast, By Drug Class
6.3.4. Europe Market Size And Forecast, By Distribution Channel

6.4. Asia-Pacific

6.4.1. Key Market Trends And Opportunities
6.4.2. Market Analysis, By Country

6.4.2.1. Japan

6.4.2.1.1. Japan Market Size And Forecast, By Drug Class
6.4.2.1.2. Japan Market Size And Forecast, By Distribution Channel

6.4.2.2. China

6.4.2.2.1. China Market Size And Forecast, By Drug Class
6.4.2.2.2. China Market Size And Forecast, By Distribution Channel

6.4.2.3. India

6.4.2.3.1. India Market Size And Forecast, By Drug Class
6.4.2.3.2. India Market Size And Forecast, By Distribution Channel

6.4.2.4. Rest of Asia-Pacific

6.4.2.4.1. Rest of Asia-Pacific Market Size And Forecast, By Drug Class
6.4.2.4.2. Rest of Asia-Pacific Market Size And Forecast, By Distribution Channel

6.4.3. Asia-Pacific Market Size And Forecast, By Drug Class
6.4.4. Asia-Pacific Market Size And Forecast, By Distribution Channel

6.5. Lamea

6.5.1. Key Market Trends And Opportunities
6.5.2. Market Analysis, By Country

6.5.2.1. Brazil

6.5.2.1.1. Brazil Market Size And Forecast, By Drug Class
6.5.2.1.2. Brazil Market Size And Forecast, By Distribution Channel

6.5.2.2. South Africa

6.5.2.2.1. South Africa Market Size And Forecast, By Drug Class
6.5.2.2.2. South Africa Market Size And Forecast, By Distribution Channel

6.5.2.3. Saudi Arabia

6.5.2.3.1. Saudi Arabia Market Size And Forecast, By Drug Class
6.5.2.3.2. Saudi Arabia Market Size And Forecast, By Distribution Channel

6.5.2.4. Rest of Lamea

6.5.2.4.1. Rest of Lamea Market Size And Forecast, By Drug Class
6.5.2.4.2. Rest of Lamea Market Size And Forecast, By Distribution Channel

6.5.3. Lamea Market Size And Forecast, By Drug Class
6.5.4. Lamea Market Size And Forecast, By Distribution Channel

Chapter 7: Company Profiles

7.1. Astrazeneca Plc

7.1.1. Company Overview
7.1.2. Company Snapshot
7.1.3. Operating Business Segments
7.1.4. Product Portfolio
7.1.5. Business Performance

7.2. Boehringer Ingelheim International Gmbh

7.2.1. Company Overview
7.2.2. Company Snapshot
7.2.3. Operating Business Segments
7.2.4. Product Portfolio
7.2.5. Business Performance

7.3. Daiichi Sankyo Company, Limited

7.3.1. Company Overview
7.3.2. Operating Business Segments
7.3.3. Product Portfolio
7.3.4. Business Performance
7.3.5. Key Strategic Moves And Developments

7.4. Johnson & Johnson

7.4.1. Company Overview
7.4.2. Company Snapshot
7.4.3. Operating Business Segments
7.4.4. Product Portfolio
7.4.5. Business Performance

7.5. Lupin

7.5.1. Company Overview
7.5.2. Company Snapshot
7.5.3. Operating Business Segments
7.5.4. Product Portfolio
7.5.5. Business Performance

7.6. Novartis Ag.

7.6.1. Company Overview
7.6.2. Company Snapshot
7.6.3. Operating Business Segments
7.6.4. Product Portfolio
7.6.5. Business Performance

7.7. Merck & Co., Inc

7.7.1. Company Overview
7.7.2. Company Snapshot
7.7.3. Operating Business Segments
7.7.4. Product Portfolio
7.7.5. Business Performance

7.8. Pfizer Inc.

7.8.1. Company Overview
7.8.2. Company Snapshot
7.8.3. Operating Business Segments
7.8.4. Product Portfolio
7.8.5. Business Performance

7.9. Sun Pharmaceutical Industries Ltd. (Ranbaxy Laboratories)

7.9.1. Company Overview
7.9.2. Company Snapshot
7.9.3. Operating Business Segments
7.9.4. Product Portfolio
7.9.5. Business Performance
7.9.6. Key Strategic Moves And Developments

7.10. Sanofi

7.10.1. Company Overview
7.10.2. Operating Business Segments
7.10.3. Product Portfolio
7.10.4. Business Performance


LINEで送る
Share on LinkedIn
このエントリーをはてなブックマークに追加
Bookmark this on BuzzURL
Bookmark this on Yahoo Bookmark